Primary central nervous system lymphomatoid granulomatosis in a patient receiving azathioprine therapy.
Katherine Martin
L
L
Department of Internal Medicine, The Ohio State University Medical Center, Columbus, OH 43210, USA. katherine.martin@osumc.edu
Porcu
Pierluigi
P
Baiocchi
Robert A
RA
Erter
Jack W
JW
Chaudhury
Abhik Ray
AR
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects*; D016543:Central Nervous System Neoplasms / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D019693:Hepatitis, Autoimmune / Q000188:drug therapy*; D006801:Humans; D008230:Lymphomatoid Granulomatosis / Q000139:chemically induced* / Q000188:drug therapy; D014057:Tomography, X-Ray Computed
D000964:Antimetabolites, Antineoplastic; D005938:Glucocorticoids; D001379:Azathioprine